Docosahexaenoic Acid Market Share

APAC Market Forecast

Asia Pacific industry is predicted to dominate majority revenue share of 42% by 2037, impelled by growing healthcare expenditure in the region. Rising healthcare spending in healthcare may increase awareness among individuals and medical professionals about the importance of DHA in maintaining overall health.

As a result, people in the region are likely to seek out products such as DHA-enriched infant formulas, baby food, and other supplements.

North American Market Statistics

The North American docosahexaenoic acid (DHA) market is estimated to be the second largest, during the forecast timeframe led by the surging numbers of consumers who have been opting for concentrated dietary supplements to address their nutritional needs for DHA. For instance, the region's population is becoming more concerned with their own health, which has led to an increase in demand for concentrated dietary supplements to meet their nutritional needs for DHA and promote their well-being.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of docosahexaenoic acid is estimated at USD 5.25 billion.

The docosahexaenoic acid market size was over USD 4.51 billion in 2024 and is anticipated to cross USD 15.39 billion by 2037, growing at more than 9.9% CAGR during the forecast period i.e., between 2025-2037. Escalating cases of depression and surging risk of preterm births across the globe will boost the market growth.

Asia Pacific industry is predicted to dominate majority revenue share of 42% by 2037, impelled by growing healthcare expenditure in the region.

The major players in the market are Koninklijke DSM N.V., BASF SE, Croda International Plc, Cellana, Inc., Far East Microalgae Industries, Co., Ltd.(FEMICO), Pelagia AS, Corbion NV, JC Biotech Private Limited, Source Omega LLC, Shandong Yuexiang Biotechnology Co., Ltd.

Docosahexaenoic Acid Market Share